Chang-seng Liang, M.D., Ph.D.
Academic Appointment: Professor of Medicine, Boston University School of Medicine, Boston MA
Medical School: National Taiwan University College of Medicine, Taipei, Taiwan (1965)
Post-Doctorate: Research Fellowship in Medicine, Boston University Medical Center, Boston MA(1969)
Fellowship in Cardiology, Boston University Medical Center, Boston MA (1974)
Brookdale Hospital, Brooklyn NY (1967)
Anesthesiology, Boston University Hospital, Boston MA (1968)
Medicine, Boston University Hospital, Boston MA (1971)
Post Residency: Fellowship in Cardiology, Boston Medical Center, Boston MA (1999)
Board Certification: Internal medicine,Cardiovascular diseases
Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH.Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 2000 Jul 27;343(4):246-53. Erratum in: N Engl J Med 2000 Nov 16;343(20):1504. N Engl J Med 2000 Sep 21;343(12):896.
Packer M, Colucci WS, Sackner-Bernstein JD, Liang CS, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young ST, Lukas MA, Shusterman NH. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.Circulation. 1996 Dec 1;94(11):2793-9.